Bioserenity raised €15M in a Series A round in Aug 2017. The company is based in Paris, France. Investors in the round: Bpifrance, Idinvest Partners, LBO France. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €15M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
